Industries > Pharma > Drug Delivery Technologies Market Forecast 2019-2029

Drug Delivery Technologies Market Forecast 2019-2029

Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines

PUBLISHED: 27 February 2019
PAGES: 180
PRODUCT CODE: PHA0356

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The Drug Delivery Technologies market is estimated to grow at a CAGR of 8.3% in the first half of the forecast period. The Oral Drug Delivery Technologies submarket held 50% of this market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report, you will find 180-page report and you will receive 60 tables and 68 figures – all unavailable elsewhere.

The 180-page report provides clear detailed insight into the Drug Delivery Technologies market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Drug Delivery Technologies market forecasts from 2019-2029

• Drug Delivery Technologies submarket forecasts from 2019-2029 covering:
• Oral Drug Delivery Technology
• Inhalable Drug Delivery Technology
• Injectable/Implantable Drug Delivery Technology
• Transdermal Drug Delivery Technology
• Ocular Drug Delivery Technology
• Nasal/Buccal Drug Delivery Technology

This report discusses the drivers and restraints of each submarket.

• Drug Delivery Technologies Market regional and national market forecasts from 2019-2029, covering:
• North America: US, Canada, Mexico
• Europe: Germany, France, UK, Italy, Spain, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, South Korea, Rest of Asia-Pacific
• Latin America: Brazil and Rest of Latin America
• Rest of the World: Middle East, Africa

Drug Delivery Technologies Market Forecast 2019-2029

• Assessment of the leading companies in the Drug Delivery Technologies market:
• 3M
• Alkermes PLC
• Altea Therapeutics Corporation
• Antares Pharma Inc.
• Applied Pharma Research S.A. (APR)
• Becton, Dickinson & Company
• Ethypharm SA
• Glycologic Limited
• Intercell AG
• NanoPass Technologies Ltd.
• pSivida

SWOT analysis of the drug delivery technologies market

Visiongain’s study is intended for anyone requiring commercial analyses for the Drug Delivery Technologies Market and leading companies. You find data, trends and predictions.

Buy our report today Drug Delivery Technologies Market Forecast 2019-2029: Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Report Overview
1.1 Global Drug Delivery Technology Market Overview
1.2 Global Drug Delivery Technologies Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Drug Delivery Technologies: An Introduction
2.1 Drug Delivery Technologies: Strategies to Improve Existing Drugs
2.2 The Global Drug Delivery Technology Market: Methods of Administration
2.2.1 The Biopharmaceutics Classification System and Using Better Tools to Model Drug Absorption
2.2.2 Sustained/Controlled Release Systems
2.2.3 Oral Drug Delivery: Swallowing Drugs to Reach a Target
2.2.4 Pulmonary Delivery: Delivered by Inhalation
2.2.5 Injection as a Route of Drug Delivery
2.2.6 Transdermal Delivery: More Patient-Friendly
2.2.7 Various Transmucosal Delivery Routes for Delivery
2.2.8 Ocular Delivery: Overcoming Unique Barriers
2.3 Regulation in the US
2.3.1 Regulation of Combination Products
2.3.2 FDA Guidelines for Injectors
2.4 Biopharmaceuticals
2.4.1 An Introduction to the Biological Drugs Market
2.4.2 Biologics: A Rising Drugs Market
2.4.3 Biologics with Associated Drug Delivery Technologies
2.4.4 PEGylated Interferons
2.4.5 Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
2.4.6 The Main Challenges Facing Biological Drug Delivery
2.5 Market Definition

3. Drug Delivery Technology: Global Market Forecast 2019-2029
3.1 The Global Drug Delivery Technology Market in 2018
3.2 The Global Drug Delivery Technology Market Forecast 2019-2029
3.3 Drug Delivery Technology: Drivers and Restraints 2019-2029
3.4 Biologics: A Driver for Growth in Drug Delivery Technologies
3.4.1 The Global Biological Drugs Market Forecast
3.4.2 Leading Classes of Biological Drugs
3.4.3 Monoclonal Antibodies: Largest Sector in Biologics
3.4.4 Human insulin: Leading the Therapeutic Protein Segment
3.4.5 Interferon Products for the Treatment of Hepatitis
3.5 Vaccines: Meeting the Unmet Needs
3.5.1 The Global Vaccines Market Forecast

4. Drug Delivery Technologies: Submarkets Forecast 2019-2029
4.1 The Global Drug Delivery Technology Market by Submarkets
4.2 How Will Segmental Market Shares Change to 2028?
4.3 Oral Drug Delivery Technology
4.3.1 Oral Drug Delivery Technology Market Forecast 2019-2029
4.3.2 Trends and Developments
4.3.2.1 Delivering APIs to the Colon
4.3.2.2 Google Investing in Robotic Pill
4.3.3 Oral Drug Delivery Technologies: Drivers and Restraints 2019-2029
4.4 Inhalable Drug Delivery Technology
4.4.1 Inhalable Drug Delivery Technology Market Forecast 2019-2029
4.4.2 Trends and Developments
4.4.2.1 Inhalable Liposomal Antibiotics to Penetrate Biofilms
4.4.2.2 Condensation Aerosol Generated by Heat
4.4.2.3 Is Inhaled Insulin Marketable?
4.4.3 Inhalable Drug Delivery Technologies: Drivers and Restraints 2019-2029
4.5 Injectable/Implantable Delivery Technology
4.5.1 Injectable/Implantable Delivery Technology Market Forecast 2019-2029
4.5.2 Trends and Developments
4.5.2.1 Ultrasound Activated Targeted Drug Delivery
4.5.2.2 Intradermal Vaccine Delivery
4.5.2.3 First Flu Vaccine Jet Injector Approved in the US
4.5.3 Injectable/Implantable Delivery Technologies: Drivers and Restraints 2019-2029
4.6 Transdermal Drug Delivery Technology
4.6.1 Transdermal Drug Delivery Technology Market Forecast 2019-2029
4.6.2 Trends and Developments
4.6.2.1 Iontophoretic Transdermal Patch for Migraine Approved in the US
4.6.2.2 Microneedle Patch for Vaccine Delivery
4.6.2.3 Ultrasonic Waveforms to Enlarge Skin Pores
4.7 Ocular Drug Delivery Technology
4.7.1 Ocular Drug Delivery Technology Market Forecast 2019-2029
4.7.2 Trends and Developments
4.7.2.1 Non-Surgical Microinjection to Retina and Choroid to be used for Gene Therapy
4.8 Nasal/Buccal Drug Delivery Technology
4.8.1 Nasal/Buccal Drug Delivery Technology Market Forecast 2019-2029
4.8.2 Trends and Developments
4.8.2.1 Nasal Spray with Live Attenuated Influenza Vaccine
4.8.2.2 Mucosal Vaccine Delivered through the Nose or Mouth
4.8.2.3 Buccal Insulin Spray in Clinical Trials

5. Global Drug Delivery Technologies Market by Region: Forecast 2019-2029
5.1 Overview: Global Drug Delivery Technologies Market, by Region
5.2 Market Share of Global Drug Delivery Technologies Segments by Region

6. North American Drug Delivery Technologies Market: Forecast 2019-2029
6.1 Overview: North American Drug Delivery Technologies Market
6.1.1 The North American Drug Delivery Technologies Market Forecast: 2019-2029
6.2 Market Share of North American Drug Delivery Technologies Segments by Country
6.3 The US Drug Delivery Technologies Market: 2019-2029
6.3.1 Eli Lilly to Establish Drug Delivery Centre
6.3.2 The US Drug Delivery Technologies Market Forecast: 2019-2029
6.4 The Canadian Drug Delivery Technologies Market: 2019-2029
6.4.1 The Canadian Drug Delivery Technologies Market Forecast: 2019-2029
6.5 The Mexican Drug Delivery Technologies Market: 2019-2029
6.5.1 The Mexican Drug Delivery Technologies Market Forecast: 2019-2029

7. Latin American Drug Delivery Technologies Market: Forecast 2019-2029
7.1 Overview: Latin American Drug Delivery Technologies Market 2018
7.1.1 The Latin American Drug Delivery Technologies Market Forecast: 2019-2029
7.2 Market Share of Latin American Drug Delivery Technologies Segments by Country
7.3 The Brazilian Drug Delivery Technologies Market: 2019-2029
7.3.1 The Brazilian Drug Delivery Technologies Market Forecast: 2019-2029
7.4 The Rest of Latin America Drug Delivery Technologies Market: 2019-2029
7.4.1 The Rest of Latin America Drug Delivery Technologies Market Forecast: 2019-2029

8. European Drug Delivery Technologies Market: Forecast 2019-2029
8.1 Overview: European Drug Delivery Technologies Market 2018
8.1.1 The European Drug Delivery Technologies Market Forecast: 2019-2029
8.2 Market Share of European Drug Delivery Technologies Segments by Country
8.3 The German Drug Delivery Technologies Market: 2019-2029
8.3.1 The German Drug Delivery Technologies Market Forecast: 2019-2029
8.4 The French Drug Delivery Technologies Market: 2019-2029
8.4.1 The French Drug Delivery Technologies Market Forecast: 2019-2029
8.5 The UK Drug Delivery Technologies Market: 2019-2029
8.5.1 The UK Drug Delivery Technologies Market Forecast: 2019-2029
8.6 The Italian Drug Delivery Technologies Market: 2019-2029
8.6.1 The Italian Drug Delivery Technologies Market Forecast: 2019-2029
8.7 The Spanish Drug Delivery Technologies Market: 2019-2029
8.7.1 The Spanish Drug Delivery Technologies Market Forecast: 2019-2029
8.8 The Russian Drug Delivery Technologies Market: 2019-2029
8.8.1 The Russian Drug Delivery Technologies Market Forecast: 2019-2029
8.9 The Rest of European Drug Delivery Technologies Market: 2019-2029
8.9.1 The Rest of European Drug Delivery Technologies Market Forecast: 2019-2029

9. Asia-Pacific Drug Delivery Technologies Market: Forecast 2019-2029
9.1 Overview: Asia-Pacific Drug Delivery Technologies Market 2018
9.1.1 Asia-Pacific Drug Delivery Technologies Market Forecast: 2019-2029
9.2 Market Share of Asia-Pacific Drug Delivery Technologies Segments by Country
9.3 The Japanese Drug Delivery Technologies Market: 2019-2029
9.3.1 The New Sakigake Designation System May Accelerate Innovative Drug Development
9.3.2 The Japanese Drug Delivery Technologies Market Forecast: 2019-2029
9.4 The Chinese Drug Delivery Technologies Market: 2019-2029
9.4.1 The Chinese Drug Delivery Technologies Market Forecast: 2019-2029
9.5 The Indian Drug Delivery Technologies Market: 2019-2029
9.5.1 The Indian Drug Delivery Technologies Market Forecast: 2019-2029
9.6 The Australian Drug delivery technologies Market: 2019-2029
9.6.1 The Australian Drug Delivery Technologies Market Forecast: 2019-2029
9.7 South-Korean Drug Delivery Technologies Market: 2019-2029
9.7.1 South-Korean Drug Delivery Technologies Market Forecast: 2019-2029
9.8 The Rest of Asia-Pacific Drug Delivery Technologies Market: 2019-2029
9.8.1 The Rest of Asia-Pacific Drug Delivery Technologies Market Forecast: 2019-2029

10. Rest of the World Drug Delivery Technologies Market Forecast: 2019-2029
10.1 Overview: Rest of the World Drug Delivery Technologies Market 2018
10.1.1 The Rest of the World Drug Delivery Technologies Market Forecast: 2019-2029
10.2 Market Share of Rest of the World Drug delivery technologies Segments by Country
10.3 The Middle-Eastern Drug Delivery Technologies Market: 2019-2029
10.3.1 The Middle-Eastern Drug Delivery Technologies Market Forecast: 2019-2029
10.4 The African Drug Delivery Technologies Market: 2019-2029
10.4.1 The African Drug Delivery Technologies Market Forecast: 2019-2029

11. Leading Companies in the Drug Delivery Technology Market

11.1 Alkermes: Focused on Extended and Controlled Release
11.1.1 Alkermes PLC
11.1.2 Alkermes PLC: Company Overview
11.1.3 Alkermes PLC: Recent Developments
11.2 3M
11.2.1 3M: Company Overview
11.2.2 3M Company: Product Portfolio
11.2.3 3M Company: Recent Developments
11.3 Becton, Dickinson & Company: A History of Hypodermic Needles and Syringes
11.3.1 Becton, Dickinson & Company: Company Overview
11.3.2 Becton, Dickinson & Company: Recent Developments
11.4 Intercell AG
11.4.1 Intercell AG: Company Overview
11.5 Altea Therapeutics Corporation
11.5.1 Altea Therapeutics Corporation: Company Overview
11.6 Antares Pharma: Leading the Needle-Free Injector Market
11.6.1 Antares Pharma Inc.: Company Overview
11.6.2 Antares Pharma Inc.: Recent Developments
11.7 pSivida:
11.7.1 pSivida Corporation: Company Overview
11.7.2 pSivida Corporation: Recent Developments
11.8 Applied Pharma Research (APR)
11.8.1 Applied Pharma Research S.A.: Company Overview
11.8.2 Applied Pharma Research S.A.: Recent Developments
11.9 Ethypharm
11.9.1 Ethypharm S.A.: Company Overview
11.10 Glycologic
11.10.1 Glycologic Limited: Company Overview
11.11 NanoPass Technologies
11.11.1 NanoPass Technologies Ltd.: Company Overview
11.11.2 NanoPass Technologies Ltd.: Recent Developments

12. Qualitative Analysis of the Drug Delivery Technology Market 2019-2029
12.1 SWOT Analysis of the Drug Delivery Technology Market
12.2 Strengths
12.2.1 Increasing Competition and Patent Expiry in the Biologics Market
12.2.2 The Rise of Biosimilars
12.2.3 Increasing Global Diabetic Population
12.3 Weaknesses
12.3.1 Risk-Conscious Regulatory Bodies Will Make Approval Difficult
12.3.2 Companies Need to Develop a More Liberal Mindset
12.4 Opportunities
12.4.1 Nanotechnology: Innovations That Will Benefit Drug Delivery
12.4.2 Possible New Delivery Methods for Insulin
12.5 Threats
12.5.1 Increasing Specificity of Drug Development Poses Challenges to Speciality Drug Delivery Companies
12.5.2 Cost Effective Solutions May Not Be Available

13. Conclusions
13.1 The Global Drug Delivery Technologies Market in 2018
13.1.1 Current Leading Drug Delivery Technology Segments
13.1.2 Notable Drug Delivery Technology Companies
13.1.3 Current Regional Markets
13.2 Global Drug Delivery Technology Market Forecast 2019-2029
13.3 The Future of the Drug Delivery Technology Market
13.3.1 Transdermal and Injectable Drug Delivery Technologies Set for High Growth
13.3.2 Biologics and Biosimilars to Drive Market Growth

Appendices
Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Visiongain report evaluation form

List of Tables
Table 2.1 The Biopharmaceutics Classification System, Classification and Description
Table 2.2 Top 5 Biologics by Sales ($bn), 2018
Table 3.1 The Global Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
Table 3.2 Global Biological Drugs Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
Table 3.3 Global Vaccines Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
Table 4.1 The Global Drug Delivery Technology Market by Submarkets: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
Table 4.2 Leading Drug Delivery Market Segments: Share (%), 2018, 2023, and 2029
Table 4.3 Oral Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
Table 4.4 Inhalable Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
Table 4.5 Insulin Inhalers Withdrawal from the Market or Pipeline, 2017
Table 4.6 Injectable/Implantable Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
Table 4.7 Transdermal Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
Table 4.8 Ocular Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
Table 4.9 Nasal/Buccal Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
Table 5.1 Global Drug Delivery Technologies Market by region: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 6.1 North American Drug Delivery Technologies Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 6.2 The US Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 6.3 The Canadian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 6.4 The Mexican Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 7.1 Latin American Drug Delivery Technologies Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 7.2 The Brazilian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 7.3 The Rest of Latin America Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 8.1 European Drug Delivery Technologies Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 8.2 The German Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 8.3 The French Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 8.4 The UK Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 8.5 The Italian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 8.6 The Spanish Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 8.7 The Russian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 8.8 The Rest of European Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 9.1 Asia-Pacific Drug Delivery Technologies Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 9.2 The Japanese Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 9.3 The Chinese Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 9.4 The Indian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 9.5 The Australian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 9.6 South-Korean Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 9.7 The Rest of Asia-Pacific Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 10.1 Rest of the world Drug Delivery Technologies Market, by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 10.2 The Middle-Eastern Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 10.3 The African Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
Table 11.1 Akermes PLC: Company Overview
Table 11.2 Alkermes PLC: Recent Developments
Table 11.3 3M: Company Overview
Table 11.4 3M: Product Portfolio
Table 11.5 3M Company: Recent Developments
Table 11.6 Becton, Dickinson & Company: Company Overview
Table 11.7 Becton, Dickinson & Company: Recent Developments
Table 11.8 Intercell AG: Company Overview
Table 11.9 Altea Therapeutics Corporation: Company Overview
Table 11.10 Antares Pharma Inc.: Company Overview
Table 11.11 Antares Pharma Inc.: Recent Developments
Table 11.12 pSivida Corporation: Company Overview
Table 11.13 pSivida Corporation: Recent Developments
Table 11.14 Applied Pharma Research S.A.: Company Overview
Table 11.15 Applied Pharma Research S.A.: Recent Developments
Table 11.16 Ethypharm S.A.: Company Overview
Table 11.17 Glycologic Limited: Company Overview
Table 11.18 NanoPass Technologies Ltd.: Company Overview
Table 11.19 NanoPass Technologies Ltd.: Recent Developments
Table 12.1 SWOT Analysis of the Drug Delivery Technology Market, 2019-2029

List of Figures
Figure 1.1 Global Drug Delivery Technologies Market Segmentation Overview 2018
Figure 3.1 The Global Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
Figure 3.2 Drug Delivery Technologies: Market Drivers and Restraints 2019-2029
Figure 3.3 The Global Biological Drugs Market: Revenue ($m) and AGR (%), 2019-2029
Figure 4.1 Leading Drug Delivery Market Segments: CAGR (%), 2019-2024
Figure 4.2 Leading Drug Delivery Market Segments: CAGR (%), 2024-2029
Figure 4.3 Leading Drug Delivery Market Segments: CAGR (%), 2019-2029
Figure 4.4 Market Shares (%) of Leading Drug Delivery Market Segments, 2018
Figure 4.5 Market Shares (%) of Leading Drug Delivery Market Segments, 2029
Figure 4.6 Oral Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
Figure 4.7 Oral Drug Delivery Technologies: Drivers and Restraints 2019-2029
Figure 4.8 Inhalable Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
Figure 4.9 Inhalable Drug Delivery Technologies: Drivers and Restraints 2019-2029
Figure 4.10 Injectable/Implantable Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
Figure 4.11 Injectable/implantable Drug Delivery Technologies: Drivers and Restraints 2019-2029
Figure 4.12 Transdermal Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
Figure 4.13 Ocular Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
Figure 4.14 Nasal/Buccal Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
Figure 5.1 Global Drug Delivery Technologies Market by region: Market Share (%) 2018
Figure 5.2 Global Drug Delivery Technologies Market by region: Market Share (%) 2029
Figure 6.1 North American Drug Delivery Technologies Market by country: Market Share (%) 2018
Figure 6.2 North American Drug Delivery Technologies Market by country: Market Share (%) 2029
Figure 6.3 North American Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 6.4 The US Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 6.5 The Canadian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 6.6 The Mexican Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 7.1 Latin American Drug Delivery Technologies Market by country: Market Share (%) 2018
Figure 7.2 Latin American Drug Delivery Technologies Market by country: Market Share (%)2029
Figure 7.3 Latin American Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 7.4 The Brazilian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 7.5 The Rest of Latin America Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 8.1 European Drug Delivery Technologies Market by Country: Market Share (%) 2018
Figure 8.2 European Drug Delivery Technologies Market by Country: Market Share (%) 2029
Figure 8.3 European Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 8.4 The German Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 8.5 The French Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 8.6 The UK Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 8.7 The Italian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 8.8 The Spanish Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 8.9 The Russian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 8.10 The Rest of European Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 9.1 Asia-Pacific Drug Delivery Technologies Market by country: Market Share (%)2018
Figure 9.2 Asia-Pacific Drug Delivery Technologies Market, by country: Market Share (%)2029
Figure 9.3 Asia-Pacific Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 9.4 The Japanese Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 9.5 The Chinese Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 9.6 The Indian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 9.7 The Australian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 9.8 South-Korean Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 9.9 The Rest of Asia-Pacific Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 10.1 Rest of the World Drug Delivery Technologies Market by Country: Market Share (%) 2018
Figure 10.2 Rest of the World Drug Delivery Technologies Market by Country: Market Share (%) 2029
Figure 10.3 Rest of the World Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 10.4 The Middle-Eastern Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 10.5 The African Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
Figure 11.1 Alkermes PLC: Revenue ($m), 2013-2017
Figure 11.2 Alkermes PLC: Geographical Presence Share (%), 2017
Figure 11.3 3M: Revenue ($m), 2013-2017
Figure 11.4 3M: Product Segments Share (%), 2017
Figure 11.5 3M: Geographical Presence Share (%), 2017
Figure 11.6 Becton, Dickinson & Company: Revenue ($m), 2013-2017
Figure 11.7 Becton, Dickinson & Company: Geographical Presence Share (%), 2017
Figure 11.8 Becton, Dickinson & Company: Segment Share (%), 2017
Figure 11.9 Antares Pharma Inc.: Revenue ($m), 2013-2017
Figure 11.10 Antares Pharma Inc.: Segment Share (%), 2017
Figure 11.11 Antares Pharma Inc.: Segment Share (%), 2017
Figure 11.12 pSivida Corporation: Revenue ($m), 2013-2017
Figure 11.13 pSivida Corporation: Product Segments Share (%), 2017
3M
Alexza Pharmaceuticals
Alkermes
Altea Therapeutics Corporation
Alza
Antares Pharma Inc.
Applied Pharma Research S.A. (APR)
Aradigm
AstraZeneca
Bayer HealthCare Pharmaceuticals
Becton, Dickinson and Company
Biogen Idec
Bristol-Myers Squibb
C.R. Bard, Inc.
Caesarea Medical Electronics (CME)
CareFusion Corporation
Cima Labs
Clearside Biomedical
Cosmo Pharmaceuticals
CRISI Medical Systems
Eli Lilly
Ethypharm SA
Ferrer
Flamel
Genentech
Generex
Glycologic Limited
Google
IDRI
ImmusanT
Innovent Biologics
Insmed
Intercell AG
iScience Interventional Corporation
J&J
MannKind
Medimetrics
MedImmune
Merck Serono
Mucosis
NanoPass Technologies Ltd.
Nektar Therapeutics
NHTherapeutics
Nitto Denko
Novo Nordisk
NuPathe
Oramed Pharmaceuticals
Pari Pharma
Pfizer
PharmaJet
Phoenix Solutions AS
pSivida
Rani Therapeutics
Renhe Group
Sandoz
Sanofi-Aventis
Santen
Spark Therapeutics
Teva
Transdermal Specialties
VentureHealth


Organizations Mentioned in the Report
Australia Institute of Health and Welfare
Bill & Melinda Gates Foundation
Center for Disease Control and Prevention (CDC)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Center for Drug Evaluation and Research (CDER)
Emory University School of Medicine
Food and Drug Administration (FDA)
Georgia Institute of Technology
International Diabetes Federation
Japan's Ministry of Health, Labour, and Welfare (MHLW)
JDRF
The Center for Drug Evaluation (CDE)
The European Medicines Agency (EMA
World Health Organization (WHO)

Download sample pages

Complete the form below to download your free sample pages for Drug Delivery Technologies Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Drug Delivery Technologies Market Forecast 2019-2029


Do you have any custom requirements we can help you with?

Any specific country, geo region, market segment or specific company information?

Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

facebookWin a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.

Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/

Would you like a free report overview of the report of your choice?

If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com

Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Would you like to get the latest Visiongain pharma reports catalogue?

What are the dynamic growth sectors? where are the regional business opportunities?

Which technologies will prevail and who are the leading companies succeeding in these sectors and why?

If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.

If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987

  • Human Microbiome Therapeutics Market 2019-2029
  • Top 20 Urology Companies 2019
  • Global Antidepressant and Anti-Anxiety Drugs Market Forecasts 2019-2029
  • The Top 100 In-Vitro Diagnostics Companies to Watch 2019
  • Global Hypertension Drugs Market 2019-2029
  • The Next Generation Sequencing Market 2019-2029
  • Lyophilisation for Pharmaceuticals: Products and Services 2019-2029
  • Top 25 In Vitro Diagnostics (IVD) Companies 2019
  • Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market 2019-2029
  • Global Biomarkets and Technologies Market 2019-2029
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Kuwait Pharmaceutical Association
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Generic Medicines Association
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Latest Pharma news

“Biobanking market set to grow to $4.2bn by 2024” says new Visiongain report

Biobanking infrastructure is improving at a global level with the establishment of large-scale national biobanks, population biobank projects, virtual biobanks and networking at national and international level.

23 May 2019

READ

“Global Urology Devices market set to grow to $9.3bn by 2023” says new Visiongain report

The market is driven by a number of factors such as aging population, technological advancements, and increasing awareness programs.

21 May 2019

READ

“In Vitro Diagnostics (IVD) market set to grow to $91bn by 2024” says new Visiongain report

In recent years, the IVD market has experienced increased consolidation among industry participants, with significant merger and acquisition (M&A) activity, especially among larger companies as they diversify and manoeuvre for stronger positions.

14 May 2019

READ

“Indian Pharmaceutical market set to grow to $71bn by 2024” says new Visiongain report

Expected increases in the level of healthcare coverage will allow greater proportion of the population to be able to afford medical care, which is still mostly paid for out-of-pocket by patients, as a greater amount of people have health insurance to cover their medical expenses.

09 May 2019

READ

Categories

Category